Advertisement
Screener

HEARTBEAM, INC. (BEAT) Operating Income

HEARTBEAM, INC. Operating Income

HEARTBEAM, INC. (BEAT) reported Operating Income of -$5.09 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.

Financial Statements › Income Statement

us-gaap:OperatingIncomeLoss · last filed 2026-08-13

  • HEARTBEAM, INC. operating income (loss) for the quarter ending 2026-06-30 was -$5.09M.
  • HEARTBEAM, INC. operating income (loss) for the quarter ending 2026-03-31 was -$4.72M.
  • HEARTBEAM, INC. operating income (loss) for the quarter ending 2025-12-31 was -$5.31M.
  • HEARTBEAM, INC. operating income (loss) for the quarter ending 2025-09-30 was -$5.29M.
  • HEARTBEAM, INC. operating income (loss) for fiscal 2025 was -$21.14M.
  • HEARTBEAM, INC. operating income (loss) for fiscal 2024 was -$19.89M.
  • HEARTBEAM, INC. operating income (loss) for fiscal 2023 was -$15.31M.
  • HEARTBEAM, INC. operating income (loss) for fiscal 2022 was -$13.03M.
Period endOperating Income (Loss) 3 monthOperating Income (Loss) 6 monthOperating Income (Loss) 9 monthOperating Income (Loss) 12 month
2026-06-30-$5.09M
10-Q · filed 2026-08-13
-$9.81M
10-Q · filed 2026-08-13
-$15.12M
derived: sum of 3 quarters · filed 2026-08-13
-$20.41M
derived: sum of 4 quarters · filed 2026-08-13
2026-03-31-$4.72M
10-Q · filed 2026-05-13
-$10.03M
derived: sum of 2 quarters · filed 2026-05-13
-$15.32M
derived: sum of 3 quarters · filed 2026-05-13
-$20.35M
derived: sum of 4 quarters · filed 2026-08-13
2025-12-31-$5.31M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12
-$10.60M
derived: sum of 2 quarters · filed 2026-03-12
-$15.64M
derived: sum of 3 quarters · filed 2026-08-13
-$21.14M
10-K · filed 2026-03-12
2025-09-30-$5.29M
10-Q · filed 2025-11-13
-$10.33M
derived: sum of 2 quarters · filed 2026-08-13
-$15.83M
10-Q · filed 2025-11-13
-$20.77M
derived: sum of 4 quarters · filed 2026-08-13
2025-06-30-$5.04M
10-Q · filed 2026-08-13
-$10.54M
10-Q · filed 2026-08-13
-$15.48M
derived: sum of 3 quarters · filed 2026-08-13
-$20.55M
derived: sum of 4 quarters · filed 2026-08-13
2025-03-31-$5.50M
10-Q · filed 2026-05-13
-$10.45M
derived: sum of 2 quarters · filed 2026-05-13
-$15.52M
derived: sum of 3 quarters · filed 2026-05-13
-$20.61M
derived: sum of 4 quarters · filed 2026-05-13
2024-12-31-$4.94M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12
-$10.01M
derived: sum of 2 quarters · filed 2026-03-12
-$15.10M
derived: sum of 3 quarters · filed 2026-03-12
-$19.89M
10-K · filed 2026-03-12
2024-09-30-$5.07M
10-Q · filed 2025-11-13
-$10.16M
derived: sum of 2 quarters · filed 2025-11-13
-$14.94M
10-Q · filed 2025-11-13
-$19.05M
derived: sum of 4 quarters · filed 2025-11-13
2024-06-30-$5.09M
10-Q · filed 2025-08-13
-$9.87M
10-Q · filed 2025-08-13
-$13.98M
derived: sum of 3 quarters · filed 2025-08-13
-$17.72M
derived: sum of 4 quarters · filed 2025-08-13
2024-03-31-$4.78M
10-Q · filed 2025-05-13
-$8.89M
derived: sum of 2 quarters · filed 2025-05-13
-$12.63M
derived: sum of 3 quarters · filed 2025-05-13
-$15.94M
derived: sum of 4 quarters · filed 2025-05-13
2023-12-31-$4.11M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13
-$7.85M
derived: sum of 2 quarters · filed 2025-03-13
-$11.16M
derived: sum of 3 quarters · filed 2025-03-13
-$15.31M
10-K · filed 2025-03-13
2023-09-30-$3.74M
10-Q · filed 2024-11-07
-$7.05M
derived: sum of 2 quarters · filed 2024-11-07
-$11.21M
10-Q · filed 2024-11-07
-$14.94M
derived: sum of 4 quarters · filed 2024-11-07
2023-06-30-$3.31M
10-Q · filed 2024-08-14
-$7.47M
10-Q · filed 2024-08-14
-$11.21M
derived: sum of 3 quarters · filed 2024-08-14
-$14.82M
derived: sum of 4 quarters · filed 2024-08-14
2023-03-31-$4.16M
10-Q · filed 2024-05-09
-$7.89M
derived: sum of 2 quarters · filed 2024-05-09
-$11.51M
derived: sum of 3 quarters · filed 2024-05-09
-$15.04M
derived: sum of 4 quarters · filed 2024-05-09
2022-12-31-$3.74M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-20
-$7.35M
derived: sum of 2 quarters · filed 2024-03-20
-$10.88M
derived: sum of 3 quarters · filed 2024-03-20
-$13.03M
10-K · filed 2024-03-20
2022-09-30-$3.61M
10-Q · filed 2023-11-14
-$7.14M
derived: sum of 2 quarters · filed 2023-11-14
-$9.29M
10-Q · filed 2023-11-14
-$10.63M
derived: sum of 4 quarters · filed 2023-11-14
2022-06-30-$3.54M
10-Q · filed 2023-08-10
-$5.68M
10-Q · filed 2023-08-10
-$7.02M
derived: sum of 3 quarters · filed 2023-08-10
-$7.47M
derived: sum of 4 quarters · filed 2023-08-10
2022-03-31-$2.15M
10-Q · filed 2023-05-11
-$3.49M
derived: sum of 2 quarters · filed 2023-05-11
-$3.94M
derived: sum of 3 quarters · filed 2023-05-11
-$4.27M
derived: sum of 4 quarters · filed 2023-05-11
2021-12-31-$1.34M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16
-$1.79M
derived: sum of 2 quarters · filed 2023-03-16
-$2.12M
derived: sum of 3 quarters · filed 2023-03-16
-$2.29M
10-K · filed 2023-03-16
2021-09-30-$446.00K
10-Q · filed 2022-11-10
-$783.00K
derived: sum of 2 quarters · filed 2022-11-10
-$944.00K
10-Q · filed 2022-11-10
-$1.21M
derived: sum of 4 quarters · filed 2022-11-10
2021-06-30-$337.00K
10-Q · filed 2022-08-11
-$500.00K
10-Q · filed 2022-08-11
-$761.00K
derived: sum of 3 quarters · filed 2022-08-11
-$1.03M
derived: sum of 4 quarters · filed 2022-08-11
2021-03-31-$163.00K
10-Q · filed 2022-05-12
-$424.00K
derived: sum of 2 quarters · filed 2022-05-12
-$696.00K
derived: sum of 3 quarters · filed 2022-05-12
2020-12-31-$261.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24
-$533.00K
derived: sum of 2 quarters · filed 2022-03-24
-$788.00K
10-K · filed 2022-03-24
2020-09-30-$272.00K
10-Q · filed 2021-12-16
-$527.00K
10-Q · filed 2021-12-16

Similar stocks

Stock NameCountryMarket CapPE Ratio
RETRACTABLE TECHNOLOGIES INC (RVP)United States$0.021B-6.44
FEMASYS INC (FEMY)United States$0.020B-1.07
Modular Medical, Inc. (MODD)United States$0.018B-0.88
ACCURAY INC (ARAY)United States$0.027B-0.63
Glucotrack, Inc. (GCTK)United States$0.027B
SeaStar Medical Holding Corp (ICU)United States$0.015B-1.14
CERENOME, INC. (CNSY)United States$0.014B
Sintx Technologies, Inc. (SINT)United States$0.012B-1.10
NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC)United States$0.012B
PAVmed Inc. (PAVM)United States$0.031B-3.00